Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int. 2000;86(3):203–7. View ArticleSymbas NP, Townsend MF, El-Galley R, Keane TE, Graham SD, Petros JA. Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU Int. ...
摘要: Publication » 456 Comparison of overall survival between the life expectancy and the estimated outcome in patients who underwent radical nephrectomy or partial nephrectomy for renal cell carcinoma.DOI: 10.1016/S1569-9056(13)60940-9 年份: 2013 ...
For patients with early-stage disease who have undergone treatment, education about possible relapse should be provided. For patient education information, see Renal Cell Cancer. Presentation History Renal cell carcinoma (RCC) may remain clinically occult for most of its course. The classic triad of...
renal cell carcinoma (RCC) is a common malignancy of the urinary system and represents a serious threat to human health. Although the overall survival of RCC has improved substantially with the development of cancer diagnosis and management, there are various reasons for treatment failure....
Studies further suggest a connection between ferroptosis and various kidney diseases: targeted iron-induced cell death may provide therapeutic benefit in acute or chronic kidney injury, diabetic nephropathy, and renal cell carcinoma [4,5,6,7]. Moreover, drugs that counteract lipid peroxidation or ...
The potential benefit of neoadjuvant toripalimab plus axitinib in cases with clear cell renal cell carcinoma (ccRCC) and inferior vena cava tumor thrombus (IVC-TT) remains unclear. NEOTAX was a phase 2 study to investigate the efficacy and safety of neoadjuvant toripalimab plus axitinib in pati...
Renal Cell Carcinoma (RCC) is the most common form of kidney cancer, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors. There are limited curable treatments available for metastatic ccRCC because this disease is unresponsive to conventional targeted systemic pharmacotherapy. Exosom...
cell nephropathy (SCN) include altered haemodynamics, hypertrophy, assorted glomerulopathies, chronic kidney disease, acute kidney injury, impaired urinary concentrating ability, distal nephron dysfunction, haematuria, and increased risks of urinary tract infections and renal medullary carcinoma. SCN largely...
Renal transplant Squamous cell carcinoma Post-transplant lymphoproliferative disorder (ptld) Sorry, something went wrong. Please try again and make sure cookies are enabledCited by (15) Extended Literature Review of the role of erythropoietin stimulating agents (ESA) use in the management of post ren...
(SRMs; renal masses ≤4 cm suspicious for cT1a renal cell carcinoma [RCC]), active surveillance (AS) has emerged as a safe initial management strategy for many patients, including those with decreased life expectancy, significant competing medical comorbidities, or very SRMs [1], [2], [3]....